Insulet
PODD
#1062
Rank
NZ$29.15 B
Marketcap
$415.22
Share price
-1.57%
Change (1 day)
48.80%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): $2.81

According to Insulet's latest financial reports the company's current EPS (TTM) is $2.89. In 2022 the company made an earnings per share (EPS) of $0.12 a decrease over its 2021 EPS that were of $0.39.

EPS history for Insulet from 2005 to 2023

2008201220162020-$100-$50$500companiesmarketcap.com

Annual EPS

Year EPS Change
2023 (TTM)$2.812288.81%
2022$0.12-69.57%
2021$0.39109.09%
2020$0.19-38.89%
2019$0.30200%
2018$0.10-113.04%
2017-$0.77-9.8%
2016-$0.86-60.77%
2015-$2.1939.78%
2014-$1.5612.05%
2013-$1.40-23.15%
2012-$1.8210.2%
2011-$1.65-36.36%
2010-$2.59-36.63%
2009-$4.09-29.36%
2008-$5.79-86.74%
2007-$43.65-64.04%
2006-$121.39122.23%
2005-$54.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.40-217.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.43-287.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.65-43.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.70 718.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.00 72.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.58 58.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$9.13 215.66%๐Ÿ‡บ๐Ÿ‡ธ USA